EXCLUSIVE OPTION AGREEMENTExclusive Option Agreement • December 10th, 2013 • Synthetic Biologics, Inc. • Pharmaceutical preparations • California
This Exclusive Option Agreement (“Agreement”) is entered into this 5th day of December, 2013 (“Effective Date”) by and among Cedars-Sinai Medical Center, a California nonprofit public benefit corporation (“CSMC”), with offices at 8700 Beverly Boulevard, Los Angeles, CA 90048, Synthetic Biologics, Inc., a Nevada corporation (hereinafter, “Synthetic”), with offices at 617 Detroit Street, Suite 100, Ann Arbor, MI 48104 and Synthetic Biomics, Inc., a Nevada corporation (hereinafter, “Company”), having offices at 617 Detroit Street, Suite 100, Ann Arbor, MI 48104 and a wholly-owned subsidiary of Synthetic (each, a “Party,” and together, the “Parties”).
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • December 10th, 2013 • Synthetic Biologics, Inc. • Pharmaceutical preparations • California
THIS EXCLUSIVE LICENSE AGREEMENT (“Agreement”) is entered into as of this 5th day of December, 2013 (“Effective Date”) by and among CEDARS-SINAI MEDICAL CENTER, a California nonprofit public benefit corporation (“CSMC”), with offices at 8700 Beverly Boulevard, Los Angeles, California 90048-1865, SYNTHETIC BIOLOGICS, INC., a Nevada corporation, with offices at 155 Gibbs Street, Suite 412, Rockville, Maryland 20850 (“Synthetic”), and SYNTHETIC BIOMICS, INC., a Nevada corporation with offices at 155 Gibbs Street, Suite 412, Rockville, Maryland 2085 which is a majority-owned subsidiary of Synthetic (the “Licensee”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • December 10th, 2013 • Synthetic Biologics, Inc. • Pharmaceutical preparations • California
THIS AGREEMENT (this “Agreement”) is made and entered into as of December 3, 2013 (the “Effective Date”), by and among Synthetic Biologics, Inc., a Nevada corporation (the “Company”), Synthetic Biomics, Inc., a Nevada corporation and wholly-owned subsidiary of the Company (“Synbiomics”), and Mark Pimentel, M.D., an individual (“Pimentel”).
STOCK PURCHASE AGREEMENT by and among SYNTHETIC BIOLOGICS, INC., SYNTHETIC BIOMICS, INC. and CEDARS-SINAI MEDICAL CENTER, INC. December 5, 2013Stock Purchase Agreement • December 10th, 2013 • Synthetic Biologics, Inc. • Pharmaceutical preparations • California
THIS AGREEMENT (“Agreement”) is made and entered into as of December 5, 2013 (the “Effective Date”), by and among Synthetic Biologics, Inc., a Nevada corporation (the “Company”), Synthetic Biomics, Inc., a Nevada corporation and wholly owned subsidiary of the Company (“Licensee”) and Cedars-Sinai Medical Center, a California nonprofit public benefit corporation (“CSMC”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • December 10th, 2013 • Synthetic Biologics, Inc. • Pharmaceutical preparations • California
THIS AGREEMENT (this “Agreement”) is made and entered into as of December 5, 2013 (the “Effective Date”), by and among Synthetic Biologics, Inc., a Nevada corporation (the “Company”), Synthetic Biomics, Inc., a Nevada corporation and wholly-owned subsidiary of the Company (“Synbiomics”), and Cedars-Sinai Medical Center, a California nonprofit public benefit corporation (“CSMC”).
